Advent declares offer for Mediq unconditional
Advent declares the public offer for all Shares in Mediq unconditional • More than 95% of the Shares tendered and accepted • Settlement will take place on 13 February 2013 • Remaining Shares can be tendered in a post acceptance period ending 12 February 2013 • Mediq to convene EGM
AI Garden B.V. (the Offeror), a company ultimately indirectly controlled by funds advised and managed by Advent International Corporation (Advent), is pleased to announce that it declares its recommended all-cash public offer (the Offer) for all the issued and outstanding ordinary shares with a nominal
value of EUR 0.25 each (the Shares) in the capital of Mediq N.V. (Mediq) unconditional (doet gestand).